Calcaterra S, Yamkovoy K, Swathi P, Ciccarone D, Del Pozo B, Englander H
Drug Alcohol Depend. 2024; 262:111409.
PMID: 39089187
PMC: 11343609.
DOI: 10.1016/j.drugalcdep.2024.111409.
Coffin P, Suen L
NEJM Evid. 2024; 2(12):EVIDra2300160.
PMID: 38320504
PMC: 11458184.
DOI: 10.1056/EVIDra2300160.
Al-Hakeim H, Altufaili M, Almulla A, Moustafa S, Maes M
Cells. 2022; 11(22).
PMID: 36429122
PMC: 9688750.
DOI: 10.3390/cells11223694.
Liu F, Cui J, Liu X, Chen K, Chen X, Li R
BMC Complement Med Ther. 2020; 20(1):161.
PMID: 32471415
PMC: 7260819.
DOI: 10.1186/s12906-020-02967-8.
Jiao D, Chen Y, Liu Y, Ju Y, Long J, Du J
Front Mol Neurosci. 2017; 10:313.
PMID: 29051727
PMC: 5633679.
DOI: 10.3389/fnmol.2017.00313.
A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
Alexander P, Gicas K, Willi T, Kim C, Boyeva V, Procyshyn R
Psychopharmacology (Berl). 2017; 234(9-10):1535-1547.
PMID: 28190084
DOI: 10.1007/s00213-017-4551-7.
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities.
Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T
Neuropsychiatr Dis Treat. 2016; 12:3195-3198.
PMID: 28008256
PMC: 5167479.
DOI: 10.2147/NDT.S120374.
Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.
Zhao Y, Zhang K, Jiang H, Du J, Na Z, Hao W
J Neuroimmune Pharmacol. 2016; 11(3):542-8.
PMID: 27108111
DOI: 10.1007/s11481-016-9671-z.
Reduced Prefrontal Cortex Hemodynamic Response in Adults with Methamphetamine Induced Psychosis: Relevance for Impulsivity.
Yamamuro K, Kimoto S, Iida J, Kishimoto N, Nakanishi Y, Tanaka S
PLoS One. 2016; 11(4):e0152373.
PMID: 27050450
PMC: 4822936.
DOI: 10.1371/journal.pone.0152373.
Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia.
Yamamuro K, Makinodan M, Kimoto S, Kishimoto N, Morimoto T, Toritsuka M
Sci Rep. 2015; 5:12107.
PMID: 26178613
PMC: 4503985.
DOI: 10.1038/srep12107.
The role of the GABA system in amphetamine-type stimulant use disorders.
Jiao D, Liu Y, Li X, Liu J, Zhao M
Front Cell Neurosci. 2015; 9:162.
PMID: 25999814
PMC: 4419710.
DOI: 10.3389/fncel.2015.00162.
Methamphetamine psychosis: epidemiology and management.
Glasner-Edwards S, Mooney L
CNS Drugs. 2014; 28(12):1115-26.
PMID: 25373627
PMC: 5027896.
DOI: 10.1007/s40263-014-0209-8.
The neurobiology of methamphetamine induced psychosis.
Hsieh J, Stein D, Howells F
Front Hum Neurosci. 2014; 8:537.
PMID: 25100979
PMC: 4105632.
DOI: 10.3389/fnhum.2014.00537.
Sex-specific brain deficits in auditory processing in an animal model of cocaine-related schizophrenic disorders.
Broderick P, Rosenbaum T
Brain Sci. 2014; 3(2):504-20.
PMID: 24961412
PMC: 4061862.
DOI: 10.3390/brainsci3020504.
Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
Salo R, Fassbender C, Iosif A, Ursu S, Leamon M, Carter C
Psychiatry Res. 2013; 210(2):529-35.
PMID: 23896355
PMC: 3818411.
DOI: 10.1016/j.psychres.2013.06.030.
Methamphetamine-associated psychosis: a new health challenge in Iran.
Alam Mehrjerdi Z, Barr A, Noroozi A
Daru. 2013; 21(1):30.
PMID: 23577655
PMC: 3637332.
DOI: 10.1186/2008-2231-21-30.
Methamphetamine-associated psychosis.
Grant K, LeVan T, Wells S, Li M, Stoltenberg S, Gendelman H
J Neuroimmune Pharmacol. 2011; 7(1):113-39.
PMID: 21728034
PMC: 3280383.
DOI: 10.1007/s11481-011-9288-1.
Methamphetamine and paranoia: the methamphetamine experience questionnaire.
Leamon M, Flower K, Salo R, Nordahl T, Kranzler H, Galloway G
Am J Addict. 2010; 19(2):155-68.
PMID: 20163388
PMC: 3168774.
DOI: 10.1111/j.1521-0391.2009.00014.x.
Mechanisms of acute cocaine toxicity.
Heard K, Palmer R, Zahniser N
Open Pharmacol J. 2009; 2(9):70-78.
PMID: 19568322
PMC: 2703432.
DOI: 10.2174/1874143600802010070.
Treatment for amphetamine psychosis.
Shoptaw S, Kao U, Ling W
Cochrane Database Syst Rev. 2009; (1):CD003026.
PMID: 19160215
PMC: 7004251.
DOI: 10.1002/14651858.CD003026.pub3.